Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia

Patrick D. Thornton, Alicja M. Gruszka-Westwood, Rifat A. Hamoudi, Shayne Atkinson, Pawel Kaczmarek, Ricardo M. Morilla, Benjamin L. Hilditch, Roger A'Hern, Estella Matutes, Daniel Catovsky

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Abnormalities of TP53 in chronic lymphocytic leukaemia (CLL) correlate with aggressive disease and transformation. We studied 115 patients with CLL including 90 untreated, 25 with heavily pretreated/refractory CLL using fluorescent in situ hybridisation (FISH) to detect allelic loss at chromosome 17p and flow cytometry (FC) to test p53 protein overexpression. A total of 17 cases were identified with TP53 deletion and/or protein expression. Both tests correlated in 10 of 17 patients; in six, one or the other abnormality was detected and in one case, with a deletion, flow cytometry failed. Material for direct DNA sequencing was available in 14 of 17 cases. Mutations were found in seven cases. Five of 14 patients with allelic loss and seven of 13 expressing p53 protein had a mutation. These were single-base substitutions and were located in exons 5, 7 or 8. Mutations were not found in 13 of 14 other cases without deletions by FISH or protein expression. The incidence of p53 abnormalities in this series was 15%, with a significant difference between untreated patients (7%) and the pretreated/refractory group (50%; P

Original languageEnglish
Pages (from-to)47-54
Number of pages8
JournalHematology Journal
Volume5
Issue number1
DOIs
Publication statusPublished - 2004

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Loss of Heterozygosity
Fluorescence In Situ Hybridization
Mutation
Flow Cytometry
Proteins
DNA Sequence Analysis
Exons
Chromosomes
Incidence

Keywords

  • CLL
  • P53
  • Therapy
  • TP53

ASJC Scopus subject areas

  • Hematology

Cite this

Thornton, P. D., Gruszka-Westwood, A. M., Hamoudi, R. A., Atkinson, S., Kaczmarek, P., Morilla, R. M., ... Catovsky, D. (2004). Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia. Hematology Journal, 5(1), 47-54. https://doi.org/10.1038/sj.thj.6200325

Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia. / Thornton, Patrick D.; Gruszka-Westwood, Alicja M.; Hamoudi, Rifat A.; Atkinson, Shayne; Kaczmarek, Pawel; Morilla, Ricardo M.; Hilditch, Benjamin L.; A'Hern, Roger; Matutes, Estella; Catovsky, Daniel.

In: Hematology Journal, Vol. 5, No. 1, 2004, p. 47-54.

Research output: Contribution to journalArticle

Thornton, PD, Gruszka-Westwood, AM, Hamoudi, RA, Atkinson, S, Kaczmarek, P, Morilla, RM, Hilditch, BL, A'Hern, R, Matutes, E & Catovsky, D 2004, 'Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia', Hematology Journal, vol. 5, no. 1, pp. 47-54. https://doi.org/10.1038/sj.thj.6200325
Thornton, Patrick D. ; Gruszka-Westwood, Alicja M. ; Hamoudi, Rifat A. ; Atkinson, Shayne ; Kaczmarek, Pawel ; Morilla, Ricardo M. ; Hilditch, Benjamin L. ; A'Hern, Roger ; Matutes, Estella ; Catovsky, Daniel. / Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia. In: Hematology Journal. 2004 ; Vol. 5, No. 1. pp. 47-54.
@article{6c417be734b54a39904fe86cfe671830,
title = "Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia",
abstract = "Abnormalities of TP53 in chronic lymphocytic leukaemia (CLL) correlate with aggressive disease and transformation. We studied 115 patients with CLL including 90 untreated, 25 with heavily pretreated/refractory CLL using fluorescent in situ hybridisation (FISH) to detect allelic loss at chromosome 17p and flow cytometry (FC) to test p53 protein overexpression. A total of 17 cases were identified with TP53 deletion and/or protein expression. Both tests correlated in 10 of 17 patients; in six, one or the other abnormality was detected and in one case, with a deletion, flow cytometry failed. Material for direct DNA sequencing was available in 14 of 17 cases. Mutations were found in seven cases. Five of 14 patients with allelic loss and seven of 13 expressing p53 protein had a mutation. These were single-base substitutions and were located in exons 5, 7 or 8. Mutations were not found in 13 of 14 other cases without deletions by FISH or protein expression. The incidence of p53 abnormalities in this series was 15{\%}, with a significant difference between untreated patients (7{\%}) and the pretreated/refractory group (50{\%}; P",
keywords = "CLL, P53, Therapy, TP53",
author = "Thornton, {Patrick D.} and Gruszka-Westwood, {Alicja M.} and Hamoudi, {Rifat A.} and Shayne Atkinson and Pawel Kaczmarek and Morilla, {Ricardo M.} and Hilditch, {Benjamin L.} and Roger A'Hern and Estella Matutes and Daniel Catovsky",
year = "2004",
doi = "10.1038/sj.thj.6200325",
language = "English",
volume = "5",
pages = "47--54",
journal = "Hematology Journal",
issn = "1466-4860",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia

AU - Thornton, Patrick D.

AU - Gruszka-Westwood, Alicja M.

AU - Hamoudi, Rifat A.

AU - Atkinson, Shayne

AU - Kaczmarek, Pawel

AU - Morilla, Ricardo M.

AU - Hilditch, Benjamin L.

AU - A'Hern, Roger

AU - Matutes, Estella

AU - Catovsky, Daniel

PY - 2004

Y1 - 2004

N2 - Abnormalities of TP53 in chronic lymphocytic leukaemia (CLL) correlate with aggressive disease and transformation. We studied 115 patients with CLL including 90 untreated, 25 with heavily pretreated/refractory CLL using fluorescent in situ hybridisation (FISH) to detect allelic loss at chromosome 17p and flow cytometry (FC) to test p53 protein overexpression. A total of 17 cases were identified with TP53 deletion and/or protein expression. Both tests correlated in 10 of 17 patients; in six, one or the other abnormality was detected and in one case, with a deletion, flow cytometry failed. Material for direct DNA sequencing was available in 14 of 17 cases. Mutations were found in seven cases. Five of 14 patients with allelic loss and seven of 13 expressing p53 protein had a mutation. These were single-base substitutions and were located in exons 5, 7 or 8. Mutations were not found in 13 of 14 other cases without deletions by FISH or protein expression. The incidence of p53 abnormalities in this series was 15%, with a significant difference between untreated patients (7%) and the pretreated/refractory group (50%; P

AB - Abnormalities of TP53 in chronic lymphocytic leukaemia (CLL) correlate with aggressive disease and transformation. We studied 115 patients with CLL including 90 untreated, 25 with heavily pretreated/refractory CLL using fluorescent in situ hybridisation (FISH) to detect allelic loss at chromosome 17p and flow cytometry (FC) to test p53 protein overexpression. A total of 17 cases were identified with TP53 deletion and/or protein expression. Both tests correlated in 10 of 17 patients; in six, one or the other abnormality was detected and in one case, with a deletion, flow cytometry failed. Material for direct DNA sequencing was available in 14 of 17 cases. Mutations were found in seven cases. Five of 14 patients with allelic loss and seven of 13 expressing p53 protein had a mutation. These were single-base substitutions and were located in exons 5, 7 or 8. Mutations were not found in 13 of 14 other cases without deletions by FISH or protein expression. The incidence of p53 abnormalities in this series was 15%, with a significant difference between untreated patients (7%) and the pretreated/refractory group (50%; P

KW - CLL

KW - P53

KW - Therapy

KW - TP53

UR - http://www.scopus.com/inward/record.url?scp=10744223348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744223348&partnerID=8YFLogxK

U2 - 10.1038/sj.thj.6200325

DO - 10.1038/sj.thj.6200325

M3 - Article

C2 - 14745430

AN - SCOPUS:10744223348

VL - 5

SP - 47

EP - 54

JO - Hematology Journal

JF - Hematology Journal

SN - 1466-4860

IS - 1

ER -